InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
6
T+90 hit rate
63%
T+90 mean return
+14.7%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Fromkin Andrew J., Director. Insider active across 1 company, notably Immunovant, Inc.. Aggregated, 18 reports have been published. Split: 2 buys · 6 sells. Total volume traded: €7.5m. History available since 10 August 2021. The latest transaction was disclosed on 28 May 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations18 total
31,668 shares@ US$4.990.0024% mcap1.5% of flowCommon StockSEC:0001341896-26-000004:0
71,492 shares@ US$7.940.0087% mcap5.5% of flowCommon StockSEC:0001341896-26-000004:1
77,181 shares@ US$8.430.010% mcap6.3% of flowCommon StockSEC:0001341896-26-000004:2
16,260 shares@ US$14.700.0037% mcap2.3% of flowCommon StockSEC:0001341896-26-000004:3
11,483 shares@ US$32.640.0058% mcap3.6% of flowCommon StockSEC:0001341896-26-000004:4
210,468 shares@ US$33.560.11% mcap68.3% of flowCommon StockSEC:0001341896-26-000004:5
19,351 shares@ US$23.1445.6% of flowCommon StockSEC:0001764013-25-000160
19,351 shares@ US$23.140.0069% mcap45.6% of flowCommon StockSEC:0001764013-25-000160:0
16,188 shares0Common StockSEC:0001764013-25-000043:0
6,616 shares@ US$19.521.3% of flowCommon StockSEC:0001764013-25-000034:0
11,255 shares0Common StockSEC:0001764013-24-000067:0
3,941 shares@ US$38.781.6% of flowCommon StockSEC:0001764013-23-000156:0
12,523 shares0Common StockSEC:0001764013-23-000045:0
21,059 shares0Common StockSEC:0001764013-22-000097:0
21,726 shares0Common StockSEC:0001764013-22-000021
21,726 shares0Common StockSEC:0001764013-22-000021:0
5,500 shares@ US$7.900.0007% mcap4.4% of flowCommon StockSEC:0001764013-21-000081:0
Ideal exit: 7 May 2022 (T+270)
5,500 shares@ US$7.900.4% of flowCommon StockSEC:0001764013-21-000081
Ideal exit: 7 May 2022 (T+270)
18 of 18 declarations
About Fromkin Andrew J.
Andrew J. Fromkin is a Director at Immunovant, Inc. As a board member, he contributes to the governance of the company, providing his expertise and strategic advice. His role is essential in guiding Immunovant's decisions and initiatives.
